These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Government action needed to step up research and development for world's most neglected diseases. Pecoul B Expert Rev Anti Infect Ther; 2005 Dec; 3(6):841-3. PubMed ID: 16307495 [No Abstract] [Full Text] [Related]
3. World pharmaceutical developments. Bale H World Hosp Health Serv; 2002; 38(2):1. PubMed ID: 12402745 [No Abstract] [Full Text] [Related]
4. Experiments in social responsibility. Herrling P Nature; 2006 Jan; 439(7074):267-8. PubMed ID: 16421547 [No Abstract] [Full Text] [Related]
5. [The production of pharmaceuticals in the world will become polarized]. Eränkö P Duodecim; 2003; 119(17):1605-6. PubMed ID: 14587438 [No Abstract] [Full Text] [Related]
6. Are rich nations up for drug reform? Check E Nature; 2006 May; 441(7090):135. PubMed ID: 16688137 [No Abstract] [Full Text] [Related]
7. Deals landscape: notable deals in the pharmaceutical industry in the third quarter of 2008. Glah D; Tear S IDrugs; 2008 Nov; 11(11):841-5. PubMed ID: 19024888 [No Abstract] [Full Text] [Related]
11. Vaccine venture boosts health hopes. Butler D Nature; 2009 Sep; 461(7262):323. PubMed ID: 19759588 [No Abstract] [Full Text] [Related]
12. The NIH, research institutions and industry: working together on a shared goal. Omary MB Gastroenterology; 2007 May; 132(5):1647-50. PubMed ID: 17484859 [No Abstract] [Full Text] [Related]
13. The pharmaceutical industry. Bartley JR N Z Med J; 1981 Dec; 94(697):431-2. PubMed ID: 6950285 [No Abstract] [Full Text] [Related]
14. [Drug industry and neglected diseases]. Flaten O; Korsvold J Tidsskr Nor Laegeforen; 2007 Feb; 127(3):319. PubMed ID: 17279114 [No Abstract] [Full Text] [Related]
15. TRIPS, pharmaceuticals, developing countries, and the Doha "solution". Sykes AO Chic J Int Law; 2002; 3(1):47-68. PubMed ID: 15709299 [No Abstract] [Full Text] [Related]
16. Paying a high price for low costs: why there should be no legal constraints on the profits that can be made on drugs for tropical diseases. Sonderholm J J Med Ethics; 2009 May; 35(5):315-9. PubMed ID: 19407038 [TBL] [Abstract][Full Text] [Related]
18. From basic research to product development: not an easy way. Moncayo A Infect Genet Evol; 2003 Sep; 3(3):157-8. PubMed ID: 14522178 [No Abstract] [Full Text] [Related]
19. Antibiotics at the crossroads. Nathan C Nature; 2004 Oct; 431(7011):899-902. PubMed ID: 15496893 [No Abstract] [Full Text] [Related]
20. A changing drug supply. Nature; 2007 Feb; 445(7127):460. PubMed ID: 17268432 [No Abstract] [Full Text] [Related] [Next] [New Search]